Cardiorenal syndrome in COVID-19
نویسندگان
چکیده
منابع مشابه
Prevalence of Psychological Disorders in Patients with COVID-19 Syndrome
A B S T R A C T The coronavirus 2019 first broke out on December 17, 2019 in Wuhan, China, and on March 11, 2020, it was announced as a worldwide pandemic by the World Health Organization. Despite nutritious diets and promising vaccines, health tips such as wearing a mask, social distancing, home quarantine, and not traveling are still the best ways to control the spread of COVID-19.While the ...
متن کاملPatients with Down syndrome in the coronavirus Pandemic (Covid 19)
Background and purpose: Coronavirus (QUID-19) is an infectious disease of the respiratory system that has been identified by the World Health Organization as an epidemic. Patients with Down syndrome are more likely to develop Quidd-19 disease with more severe complications due to the underlying comorbidities they have. The aim of this study was to evaluate the complications of Covid-19 disease...
متن کاملCardiorenal syndrome.
Very often, physicians confront with patients who have concomitant heart and kidney failure. The coexistence of kidney and heart failure carries an extremely bad prognosis. The exact cause of deterioration of kidney function and the mechanism underlying this interaction are complex, multifactorial in nature, and still not completely understood. Both the heart and the kidney act in tandem to reg...
متن کاملCardiorenal syndrome
Kidney dysfunction in patients with heart failure and cardiovascular disorders in patients with chronic kidney disease are common. A recently proposed consensus definition of cardiorenal syndrome stresses the bidirectional nature of these heart-kidney interactions. The treatment of cardiorenal syndrome is challenging, however, promising new therapeutic options are currently being investigated i...
متن کاملNitric oxide mediated the effects of nebivolol in cardiorenal syndrome
Objective(s): Despite several proposed mechanisms for the pathophysiology of cardiorenal syndrome (CRS), the exact mechanism remains unclear. Nitrosative stress has been argued as a key mechanism recently. Nebivolol is a beta-blocker with nitric oxide (NO)-releasing effect. In the present study, NO-mediated effects of two different treatment regimes of nebivolol in CRS...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ Case Reports
سال: 2021
ISSN: 1757-790X
DOI: 10.1136/bcr-2021-241914